ANIX
Anixa Biosciences Inc
+0.08 (+3.08%)2.68USD166K成交股數93.2M市值–本益比(近四季)443.6股價營收比–營收年增(近四季)2026-09-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 10 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.3M | 1.3M | 1.1M | 1.1M | 1.1M | 1.3M | 1.6M | 1.9M | 1.6M | 1.3M | 1.6M | 1.1M |
| 銷售管理費用 | 1.4M | 1.4M | 1.6M | 1.7M | 1.4M | 1.7M | 1.8M | 1.7M | 1.8M | 2.3M | 1.4M | 1.8M |
| 營業利益 | −2.7M+12% | −2.6M-12% | −2.7M-20% | −2.9M-20% | −2.4M-30% | −3.0M-17% | −3.4M+11% | −3.6M+26% | −3.5M | −3.6M | −3.1M | −2.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −2.6M+15% | −2.5M-10% | −2.6M-19% | −2.7M-18% | −2.3M-28% | −2.8M-14% | −3.2M+18% | −3.3M+31% | −3.1M | −3.3M | −2.7M | −2.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.08+14% | -0.07-22% | -0.08-20% | -0.08-20% | -0.07-30% | -0.09-10% | -0.10-60% | -0.10+25% | -0.10 | -0.10 | -0.25 | -0.08 |
| 稀釋股數 | 34.2M | 33.6M | 33.2M | 32.5K | 32.5M | 32.2M | 32.2M | 32.1M | 31.9M | 31.4M | 31.0K | 31.0K |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.4M | 1.5M | 1.5M | 1.2M | 1.5M | 1.9M | 1.1M | 1.2M | 995K | 998K | 915K | 3.2M |
| 應收帳款 | – | 56K | – | – | – | – | – | 410K | 218K | 391K | 270K | 334K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 15.1M | 14.9M | 15.2M | 16.1M | 17.7M | 17.0M | 18.9M | 22.9M | 24.4M | 25.4M | 25.5M | 26.6M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.9M | 1.6M | 1.4M | 2.1M | 2.2M | 2.1M | 2.2M | 2.2M | 1.8M | 1.8M | 2.2M | 2.0M |
| 股東權益 | 14.5M | 14.5M | 15.1M | 15.2M | 16.6M | 16.1M | 17.9M | 21.8M | 23.6M | 24.6M | 24.3M | 25.5M |
| 負債比 | 12.4% | 11.0% | 9.1% | 13.2% | 12.7% | 12.2% | 11.6% | 9.7% | 7.3% | 7.0% | 8.4% | 7.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −2.6M-10% | – | – | – | −2.9M | – | – | −2.3M | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2019 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2019 年度 · 250K
| Patent Licensing | 250K | 100.0% | -77.5% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −10.9M | –% | -0.34 | – |
| FY2024 | 210K | 0.0% | −12.6M | -5,978.1% | -0.39 | – |
| FY2023 | 210K | – | −9.8M | -4,671.9% | -0.32 | – |
| FY2022 | – | – | −13.6M | –% | 0.45 | – |
| FY2021 | 512K | – | −13.0M | -2,530.1% | -0.45 | – |
| FY2020 | – | – | −10.0M | –% | -0.45 | −6.2M |
| FY2019 | 250K | -77.5% | −11.6M | -4,658.8% | -0.59 | −4.9M |
| FY2018 | 1.1M | – | −14.0M | -1,258.1% | -0.79 | −4.3M |